Presbia to Participate in JMP Securities Life Science Conference 2016 in New York
DUBLIN--(BUSINESS WIRE)--Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration, announced today that Todd Cooper, President and CEO, is scheduled to present at the JMP Securities Life Sciences Conference 2016 on Tuesday, June 21 at 3:00 p.m. ET. The Conference is being held June 21 and 22, 2016 at The St. Regis New York. Presbia has developed and is marketing the Presbia Flexivue Microlens™, a proprietary optical lens implant for treating presbyopia. Mr.
